Sesamol combats diabetogenic effects of atorvastatin through GLUT-4 expression and improved pancreatic viability

Statin-associated diabetes (SAD) is an issue that has come to light after a series of recent clinical trials that has led to the issue of a black box warning for statins by the US FDA. However, the benefit of statin outweighs its risk. Nevertheless, experiments have been conducted to identify the me...

Ausführliche Beschreibung